Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients
Clicks: 192
ID: 266686
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
192 views
48 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #239 of 1,084 articles by views in clinical infectious diseases
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Fluoroquinolone prophylaxis in neutropenic, hematologic malignancy patients and hematopoietic-transplant recipients is associated with breakthrough bacteremia w
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (16 words).
Try re-searching for a better abstract.
| Reference Key |
morgan2019clinicalfluoroquinolone
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Hakki, Morgan;Humphries, Romney M;Hemarajata, Peera;Tallman, Gregory B;Shields, Ryan K;Mettus, Roberta T;Doi, Yohei;Lewis, James S; |
| Journal | clinical infectious diseases |
| Year | 2019 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.